|
BBS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.63389976495887E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.33590000067829E-09 |
| Normal-vs-Stage2 |
7.144600E-03 |
| Normal-vs-Stage3 |
7.459000E-03 |
| Normal-vs-Stage4 |
2.91220000336878E-08 |
| Stage1-vs-Stage2 |
5.672800E-01 |
| Stage1-vs-Stage3 |
9.285400E-01 |
| Stage1-vs-Stage4 |
1.810790E-01 |
| Stage2-vs-Stage3 |
7.201600E-01 |
| Stage2-vs-Stage4 |
6.924000E-02 |
| Stage3-vs-Stage4 |
1.577760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.16079995510421E-09 |
| Normal-vs-AfricanAmerican |
8.74529999972395E-07 |
| Normal-vs-Asian |
4.873800E-02 |
| Caucasian-vs-AfricanAmerican |
9.414800E-01 |
| Caucasian-vs-Asian |
2.294400E-01 |
| AfricanAmerican-vs-Asian |
1.758050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.25689491936987E-11 |
| Normal-vs-Female |
7.757200E-04 |
| Male-vs-Female |
2.620600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.06419999995811E-06 |
| Normal-vs-Extreme_Weight |
9.57830004200133E-09 |
| Normal-vs-Obese |
2.405100E-04 |
| Normal-vs-Extreme_Obese |
2.544200E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.042800E-01 |
| Normal_Weight-vs-Obese |
2.973400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.473800E-01 |
| Extreme_Weight-vs-Obese |
1.840970E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.062200E-01 |
| Obese-vs-Extreme_Obese |
8.534000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.999200E-04 |
| Normal-vs-Age(41-60Yrs) |
6.3142000000016E-05 |
| Normal-vs-Age(61-80Yrs) |
2.53740362055055E-11 |
| Normal-vs-Age(81-100Yrs) |
2.178400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.621990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.595400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.039600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.176400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.898800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.902600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.26239999956412E-07 |
| Normal-VS-Type2 PRCC |
2.41269999534666E-08 |
| Normal-VS-KIRP CIMP |
4.2016390366939E-12 |
| Normal-VS-Unclassified PRCC |
1.474250E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.323590E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.0835999999953E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
5.036600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.393300E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
9.053500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.74440000000531E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.83999999575835E-08 |
| Normal-vs-N1 |
6.022400E-04 |
| Normal-vs-N2 |
2.29789999994789E-06 |
| N0-vs-N1 |
8.084000E-01 |
| N0-vs-N2 |
4.634400E-01 |
| N1-vs-N2 |
3.154200E-01 |
|
|
